IBD barriers across the continents: a continent-specific analysis: Latin America.

"Natália Sousa Freitas Queiroz has served as a speaker and advisory board member of Janssen, Takeda, and Abbvie.: Camilla de Almeida Martins has no potential conflict of interest to disclose.: Kenneth Ernest-Suarez has served as a speaker and advisory board member of Janssen, Pfizer, Sandoz, Ferring, Menarini, AstraZeneca.: Pablo A. Olivera Sendra: consulting fees from Abbvie, Takeda, and Janssen; Honoraria from Takeda and Janssen; support for attending meetings and/or travel from Abbvie, Takeda, Janssen, and Ferring.: Abel Botelho Quaresma: speaker fees for Abbvie, Janssen, and Apsen.: Paulo Gustavo Kotze: consulting and speaker fees for Abbvie, Janssen, Takeda, Pfizer, Ferring, and Novartis. Scientific grants from Pfizer and Takeda."

"Funding: The authors received no financial support for the research, authorship, and/or publication of this article."